Active, not recruitingNot applicableNCT07274826

Diagnostic Creteria of Acid Sphingomyelinase Deficiency (ASMD)

Studying Acid sphingomyelinase deficiency

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Sohag University
Enrollment: 7 enrolled
Eligibility: All sexes
Timeline: 2025 – 2026

Study locations (1)

Sohag University Hospital, Sohag, Egypt

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07274826 on ClinicalTrials.gov

Other trials for Acid sphingomyelinase deficiency

Additional recruiting or active studies for the same condition.

RECRUITINGNCT06192576
A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)
Sanofi
ENROLLING BY INVITATIONNANCT05368038
ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program
Albert Einstein College of Medicine

See all trials for Acid sphingomyelinase deficiency →

← Back to all trials